Age-related macular degeneration (AMD) is a complex eye disorder and is the leading
cause of incurable blindness worldwide in the elderly. Clinically, AMD initially affects the …

Age‐related macular degeneration (AMD) is one of the main socioeconomical health issues
worldwide. AMD has a multifactorial etiology with a variety of risk factors. Smoking is the …

Purpose To determine the frequency of neovascularization subtypes as determined by
fluorescein angiography (FA) alone vs FA and optical coherence tomography (OCT) grading …

Age-related macular degeneration (AMD) is the leading cause of severe irreversible central
vision loss in individuals over 65 years old. Genome-wide association studies (GWASs) …

Age-related macular degeneration (AMD) is the leading cause of blindness in the developed
world. It is a complex multifactorial disease, and despite new advances in treatment, many …

Age-related macular degeneration (AMD) is an inflammatory disease, which causes visual
impairment and blindness in older people. The proteins of the complement system are …

Purpose Age-related maculopathy susceptibility 2 (ARMS2) is considered the most
enigmatic of the genes for age-related macular degeneration (AMD). We investigated the …

PURPOSE: To evaluate vitreomacular relations in different stages of age-related macular
degeneration (AMD) without the influence of genetics and environmental factors. DESIGN …

A common haplotype on 10q26 influences the risk of age-related macular degeneration
(AMD) and encompasses two genes, LOC387715 and HTRA1. Recent data have suggested …

Standard care for neovascular age related macular degeneration is treatment with
monoclonal antibodies that inhibit vascular endothelial growth factor. A fifth of those treated …